• Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

BioPharma News

Biopharmaceutical industry analysis. Credible, reliable, equitable.

Subscribe
  • Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe

New Drugs

Novel drugs approved by regulators for human use.
A drug is positioned as new if it:
  • offers treatment for a disease for which no specific therapy previously existed
  • targets a new therapeutic target
  • has a new mechanism of action
  • is developed in a new formulation, optimized or improved
  • is part of a new combination drug
  • belongs to a new class of drug compounds.
Posted inNew Drugs, Regulatory

Susvimo: Pioneering Implant for Treating Wet Age-Related Macular Degeneration

by Julia Mardi January 20, 2022September 8, 2022

Roche offered a convenient replacement for the traditional Lucentis.

Candida albicans.
Posted inInfections, New Drugs, Regulatory

Brexafemme: New Drug for Vaginal Yeast Infection

by Julia Mardi January 15, 2022September 8, 2022

Scynexis offered ibrexafungerp, a new antifungal medication for vulvovaginal candidiasis treatment.

insomnia
Posted inNeuroscience, New Drugs, Regulatory

Quviviq: New Sleeping Pill

by Tanya von Reuss January 10, 2022November 5, 2022

Daridorexant will help treat insomnia.

Molnupiravir
Posted inCOVID-19, Infections, New Drugs, Regulatory

Molnupiravir Approved in the U.S.

by Tanya von Reuss December 23, 2021September 8, 2022

An oral antiviral drug by Merck & Co. has joined the armamentarium of the pharmacological fight against COVID-19.

Posted inCOVID-19, Infections, New Drugs, Regulatory

MIR 19: Surprising New Drug to Treat Coronavirus

by Mark Gubar December 23, 2021September 8, 2022

A Russian drug for COVID-19 has adopted a powerful RNA interference technology.

Posted inCardiology, Metabolism, New Drugs, Rare/Orphan Diseases, Regulatory

Leqvio: Newest Drug Against ‘Very Bad’ Cholesterol

by Mark Gubar December 23, 2021April 5, 2024

Two injections of inclisiran a year and you can forget about high cholesterol. Novartis doesn’t lie.

Paxlovid (nirmatrelvir + ritonavir).
Posted inCOVID-19, Infections, New Drugs, Regulatory

Paxlovid Approved in the U.S.

by Tanya von Reuss December 22, 2021September 8, 2022

Pfizer’s oral antiviral drug has entered the world’s main pharmaceutical market.

Posts pagination

Newer posts 1 … 6 7 8 9 10 … 13 Older posts
BioPharma News Logo
Biopharmaceutical industry analysis.
© 2025 BioPharma News Powered by Newspack Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

Awareness and enlightenment are strengths.

BioPharma News is an amazing and trustworthy non-profit data analysis service that provides honest and objective reporting on the Pharma & Biotech industry. We would like to invite you to sign up for our weekly Newsletter to stay informed and uptodate.

Please check your inbox or spam folder for an email from [email protected] to confirm your subscription.

×